-
5 Active Stocks: Xilinx Inc. (NASDAQ:XLNX), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Atossa Genetics (NASDAQ:ATOS), NeuStar (NYSE:NSR), Arena Pharmaceuticals (NASDAQ:ARNA)
Xilinx Inc. (NASDAQ:XLNX) on 5 March 2015, announced immediate availability of the winter 2015 edition of its award-winning user magazine, Xcell Journal. The cover story for the 90th issue of Xcell Journal takes a system-level look at Xilinx’s newly unveiled UltraScale+™ product portfolio of FPGAs, 3D ICs, and MPSoCs, and how the portfolio yields a…
-
Investors Are Eying: Tesla Motors Inc (NASDAQ:TSLA), Capnia (NASDAQ:CAPN), On Track Innovations (NASDAQ:OTIV), Heat Biologics (NASDAQ:HTBX), Arena Pharmaceuticals (NASDAQ:ARNA)
Tesla Motors Inc. (NASDAQ:TSLA) said it’s cutting jobs in China after a local newspaper reported the company will reduce staff by 30 percent. Tesla will eliminate some positions as it makes structural changes to its business in China, Gary Tao, a local spokesman for the carmaker, said Monday by phone. On Friday shares of Tesla…
-
• Stocks News Alert: La Jolla Pharmaceutical Co. (NASDAQ:LJPC), Alteva (NYSEMKT:ALTV), American Residential Properties (NYSE:ARPI), Arena Pharmaceuticals (NASDAQ:ARNA), Limelight Networks (NASDAQ:LLNW)
Equities researchers at Chardan Capital initiated coverage on shares of La Jolla Pharmaceutical Co (NASDAQ:LJPC) in a research report issued on Monday. The firm set a “buy” rating and a $54.00 price target on the stock. On Friday shares of La Jolla Pharmaceutical Co. (NASDAQ:LJPC) closed at $23.27. On February 26, it was reported that,…
-
Why Trader’s Are Watching: Nokia Corporation (ADR) (NYSE:NOK), Glori Energy (NASDAQ:GLRI), Neonode (NASDAQ:NEON), Galena Biopharma (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA)
Fresh reports have emerged claiming that Nokia Corporation (ADR) (NYSE:NOK) is developing a new smartphone called the Nokia 1100 that is powered by Android 5.0 Lollipop. Following its recent acquisition by Microsoft, the “new” Nokia has been expected to come up with new smartphones. However, its deal with Microsoft does not allow the Finnish company…
-
Active Movers: Second Sight Medical Products (NASDAQ:EYES), eBay Inc. (NASDAQ:EBAY), Aeterna Zentaris Inc. (NASDAQ:AEZS), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Arena Pharmaceuticals (NASDAQ:ARNA)
Second Sight Medical Products, Inc. (Nasdaq: EYES) announced that two newly approved centers, located in Camposampiero and Florence, have successfully completed their first commercial implants of the Argus II Retinal Prosthesis System (“Argus II”) in patients with outer retinal degeneration. On Thursday shares of Second Sight Medical Products, Inc. (NASDAQ:EYES) closed at $17.07. Morgan Stanley…
-
Top Movers: Active Power Inc. (NASDAQ:ACPW), Arena Pharmaceuticals (NASDAQ:ARNA), SUPERVALU Inc. (NYSE:SVU), Wix.com (NASDAQ:WIX), Clovis Oncology (NASDAQ:CLVS)
Active Power, Inc. (NASDAQ: ACPW), has been invited to present at the 27th Annual ROTH Conference being held March 8-11, 2015, at the Ritz Carlton in Dana Point, Calif. On Thursday shares of Active Power Inc. (NASDAQ:ACPW) closed at $2.49. Company’s sales growth for last 5 years was 7.50% and EPS growth for next 5…
-
Big Movers in Focus: General Electric Company (NYSE:GE), Tesla Motors Inc (NASDAQ:TSLA), Teekay Tankers (NYSE:TNK), Arena Pharmaceuticals (NASDAQ:ARNA), Baidu Inc (NASDAQ:BIDU)
Two General Electric Company (NYSE:GE)’s divisions led by Cleveland State University graduates have committed $500,000 towards scholarships for CSU students pursuing science, technology, engineering or math degrees. GE Lighting and GE Transportation established the GE Scholars program, which will award five full-tuition scholarships each year for 10 years, beginning this fall. On Wednesday shares of…
-
Watch 5 Stocks: Arena Pharmaceuticals (NASDAQ:ARNA), The Dow Chemical Company (NYSE:DOW), BP p.l.c. (NYSE:BP), Beacon Roofing Supply (NASDAQ:BECN), Ariad Pharmaceuticals (NASDAQ:ARIA)
On March 2, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported a fourth-quarter 2014 loss of 15 cents per share, wider than the Zacks Consensus Estimate of a loss of 13 cents and the year-ago loss of 11 cents. Total revenues increased 41.1% year over year to $9.2 million, lagging the Zacks Consensus Estimate of $10 million. On…
-
What’s Hot: Arena Pharmaceuticals (NASDAQ:ARNA), Merck & Co. Inc. (NYSE:MRK), Daegis Inc. (NASDAQ:DAEG), DIRECTV (NASDAQ:DTV), Citigroup Inc. (NYSE:C)
On March 2, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported a loss for the fourth quarter that widened from last year, despite a revenue surge, reflecting higher research and development expenses. Total revenues for the quarter surged to $9.19 million from $6.52 million in the same quarter last year, but missed ten Wall Street analysts’ consensus estimate…
-
Traders Are Gambling on: Arena Pharmaceuticals (NASDAQ:ARNA), Weibo Corporation (NASDAQ:WB), Francesca’s Holdings Corporation (NASDAQ:FRAN), Clean Diesel Technologies Inc. (NASDAQ:CDTI), AxoGen (NASDAQ:AXGN)
On 2 March, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported Revenues totaled $9.2 million, including $3.8 million in net product sales of BELVIQ, of which $3.2 million represented 31.5% of Eisai’s net product sales and $0.6 million related to redemptions of the 15-day free voucher and product samples. On Wednesday shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) closed…